Idarubicin Hydrochloride

Overview

Idarubicin Hydrochloride is an anthracycline antineoplastic used in the treatment of certain types of cancer, including acute myeloid leukemia. It works by intercalating DNA, thereby inhibiting the synthesis of nucleic acids and causing cell death.

API suppliers (3)

Suppliers of Idarubicin Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• TAPI NL BV1 active DMF
• SYNBIAS PHARMA AG
• PHARMACIA AND UPJOHN CO WHOLLY OWNED SUB PFIZER INC

Therapeutic areas